Active	Status	Sponsor type	Region	Phase	Filter
2 Active 0 Inactive 2 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

2 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Dubov, Vitaly
NCT06429150: Frontline Combination CAR-T Cell Therapy for Multiple Myeloma or Plasmacytoma	Recruiting	1/2	20	RoW	CAR-T cells	Shenzhen Geno-Immune Medical Institute, The No.2 Clinical Hospital of the Ministry of Health	Multiple Myeloma, Plasmacytoma	07/27	12/27
NCT06435910: Engineered Dendritic Cell Vaccines for Multiple Myeloma	Recruiting	1	10	RoW	DC vaccines	Shenzhen Geno-Immune Medical Institute, The No.2 Clinical Hospital of the Ministry of Health	Multiple Myeloma or Plasmacytoma	07/27	12/27